Cargando…
Pure red cell aplasia accompanied by COVID-19 successfully treated using cyclosporine
A 67-year-old Japanese man was admitted to our hospital with severe coronavirus disease 2019 (COVID-19) in March 2020. Mechanical ventilation was initiated 8 days after admission, due to severe respiratory failure. Multiple severe complications such as liver dysfunction, arrhythmia, brain infarction...
Autores principales: | Yamazaki, Susumu, Naito, Erika, Sekiya, Ryu, Yogi, Sanehiro, Komiyama, Kenichiro, Miyakawa, Yoshitaka, Nagata, Makoto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542443/ https://www.ncbi.nlm.nih.gov/pubmed/34772624 http://dx.doi.org/10.1016/j.jiac.2021.10.018 |
Ejemplares similares
-
Durvalumab-Induced Secondary Pure Red Cell Aplasia Successfully Treated With Cyclosporin
por: Watanabe, Kageaki, et al.
Publicado: (2020) -
Pure red cell aplasia associated with autoimmune hepatitis successfully treated with cyclosporine A
por: Sato, Akira, et al.
Publicado: (2014) -
Angioimmunoblastic T-cell lymphoma accompanied by pure red cell aplasia: A case report
por: Kawahigashi, Teiko, et al.
Publicado: (2020) -
Case Report: Successful Treatment of Steroid-Refractory Immune Checkpoint Inhibitor-Related Pure Red Cell Aplasia With Cyclosporin
por: Gérard, Alexandre, et al.
Publicado: (2020) -
Myelodysplastic Syndrome with Erythroid Aplasia following Pure Red Cell Aplasia
por: Kim, Hyoung Doo, et al.
Publicado: (2004)